QuickLinks -- Click here to rapidly navigate through this document
EXHIBIT 10.1
COMPENSATION OF NAMED EXECUTIVE OFFICERS
| Name and Position | Fiscal 2005 Base Salary ($) | Fiscal 2006 Base Salary ($) | Fiscal 2005 Bonus ($) | |||
|---|---|---|---|---|---|---|
| Peter D. Meldrum President and Chief Executive Officer | 580,000 | 615,000 | 290,000 | |||
| Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc. | 400,000 | 424,000 | 170,000 | |||
| Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc. | 400,000 | 424,000 | 170,000 | |||
| Jay M. Moyes Vice President of Finance, Chief Financial Officer | 308,000 | 326,500 | 100,000 | |||
| Mark H. Skolnick, Ph.D.(1) Chief Scientific Officer | 420,000 | 445,000 | 105,000 |
- (1)
- Dr. Skolnick is compensated on an hourly basis. Base salary information reflects an annualized salary based on 2080 hours worked in a fiscal year. Actual amounts paid to Dr. Skolnick may vary significantly depending on the actual number of hours worked.
COMPENSATION OF NAMED EXECUTIVE OFFICERS